NewAmsterdam Pharma N.V. (NAMS)
undefined
undefined%
At close: undefined
24.00
-2.00%
After-hours Dec 13, 2024, 05:54 PM EST

NewAmsterdam Pharma N.V. Forcast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for NAMS stock have an median target of 33.5, with a low estimate of 30 and a high estimate of 37. The median target predicts an increase of 36.79% from the current stock price of 24.49.

Analyst Consensus: Buy
Target Low Average Median High
Price $30 $33.5 $33.5 $37
Change 22.50% 36.79% 36.79% 51.08%

AI Analyst Report

Needham has maintained a Buy rating on NewAmsterda... Unlock content with Pro Subscription

Updated Nov 21, 2024

Rating Jun 24Jul 24Aug 24Sep 24Nov 24Dec 24
Strong Buy 000000
Buy 111232
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 1 2 3 2

Financial Forecast this Year

Revenue This Year
12.15M
from 12.76M
Increased by -4.8%
Revenue Next Year
8.76M
from 12.15M
Increased by -27.9%
EPS This Year
-2.18
from -1.95
Increased by -11.8%
EPS Next Year
-1.59
from -2.18
Increased by 27.1%